S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Bayer Aktiengesellschaft (BAYRY) Stock Forecast, Price & News

+0.12 (+0.71%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
364,512 shs
Average Volume
577,338 shs
Market Capitalization
$66.57 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Bayer Aktiengesellschaft logo

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.


See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$52.16 billion
Cash Flow
$2.91 per share
Book Value
$9.99 per share


Net Income
$1.18 billion
Pretax Margin




Outstanding Shares
Free Float
Market Cap
$66.57 billion
Not Optionable

Company Calendar

Last Earnings
Ex-Dividend for 5/16 Dividend
Dividend Payable
Fiscal Year End

Social Links


Overall MarketRank

2.29 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Frequently Asked Questions

Is Bayer Aktiengesellschaft a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer Aktiengesellschaft in the last twelve months. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Bayer Aktiengesellschaft stock.
View analyst ratings for Bayer Aktiengesellschaft
or view top-rated stocks.

Are investors shorting Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 102,800 shares, a decrease of 55.7% from the April 15th total of 232,200 shares. Based on an average daily trading volume, of 1,052,700 shares, the days-to-cover ratio is currently 0.1 days.
View Bayer Aktiengesellschaft's Short Interest

How were Bayer Aktiengesellschaft's earnings last quarter?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) released its quarterly earnings results on Tuesday, March, 1st. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.10. The firm had revenue of $12.72 billion for the quarter, compared to analyst estimates of $11.68 billion. Bayer Aktiengesellschaft had a trailing twelve-month return on equity of 22.39% and a net margin of 4.29%.
View Bayer Aktiengesellschaft's earnings history

How often does Bayer Aktiengesellschaft pay dividends? What is the dividend yield for Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft announced a dividend on Friday, April 29th. Stockholders of record on Tuesday, May 3rd will be paid a dividend of $0.3693 per share on Monday, May 16th. This represents a yield of 2.26%. The ex-dividend date is Monday, May 2nd.
View Bayer Aktiengesellschaft's dividend history

Is Bayer Aktiengesellschaft a good dividend stock?

Bayer Aktiengesellschaft pays an annual dividend of $0.35 per share and currently has a dividend yield of 2.08%. The dividend payout ratio of Bayer Aktiengesellschaft is 59.32%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 16.75% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.
View Bayer Aktiengesellschaft's dividend history.

What guidance has Bayer Aktiengesellschaft issued on next quarter's earnings?

Bayer Aktiengesellschaft issued an update on its FY 2022 earnings guidance on Tuesday, May, 17th. The company provided EPS guidance of $7.86-$7.86 for the period. The company issued revenue guidance of $51.64 billion-$51.64 billion, compared to the consensus revenue estimate of $51.59 billion.

What price target have analysts set for BAYRY?

11 analysts have issued twelve-month target prices for Bayer Aktiengesellschaft's stock. Their forecasts range from $60.00 to $96.00. On average, they anticipate Bayer Aktiengesellschaft's stock price to reach $82.25 in the next year. This suggests a possible upside of 385.5% from the stock's current price.
View analysts' price targets for Bayer Aktiengesellschaft
or view top-rated stocks among Wall Street analysts.

Who are Bayer Aktiengesellschaft's key executives?
Bayer Aktiengesellschaft's management team includes the following people:
  • Mr. Werner Baumann, Chairman of Management Board, CEO & Chief Sustainability Officer (Age 60, Pay $6.05M)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 53, Pay $2.39M)
  • Mr. Heiko W. J. Schipper, Member of Management Board & Pres of the Consumer Health Division (Age 53, Pay $2.58M)
  • Mr. Stefan Oelrich, Head of the Pharmaceuticals Division & Member of the Board of Management (Age 54, Pay $3.19M)
  • Ms. Sarena S. Lin, Chief Transformation & Talent Officer, Labor Director and Member of Management Board (Age 51, Pay $3.36M)
  • Mr. Rodrigo Santos, Member of Management Board & Pres of the Crop Science Division (Age 49)
  • Mr. Bernd-Peter Bier, Head of Accounting and Head of Taxes (Age 55)
  • Mr. Oliver Maier, Head of Investor Relations
  • Dr. Gabriel Harnier, Head of Law, Patents & Compliance (Age 51)
  • Mr. Michael Preuss, Head of Communications, Gov. Relations and Corp. Brand
What is Bayer Aktiengesellschaft's stock symbol?

Bayer Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "BAYRY."

How do I buy shares of Bayer Aktiengesellschaft?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bayer Aktiengesellschaft's stock price today?

One share of BAYRY stock can currently be purchased for approximately $16.94.

How much money does Bayer Aktiengesellschaft make?

Bayer Aktiengesellschaft has a market capitalization of $66.57 billion and generates $52.16 billion in revenue each year. The company earns $1.18 billion in net income (profit) each year or $0.589990 on an earnings per share basis.

How many employees does Bayer Aktiengesellschaft have?

Bayer Aktiengesellschaft employs 99,637 workers across the globe.

Does Bayer Aktiengesellschaft have any subsidiaries?

The following companies are subsidiares of Bayer Aktiengesellschaft: AB Seeds Ltd, AB Seeds Sales (2006) Ltd, AO Bayer, Adverio Pharma GmbH, AgrEvo Verwaltungsgesellschaft mbH, AgraQuest Inc., Alcafleu Management GmbH & Co. KG, Algeta, Artificial Muscle Inc, Asklepios BioPharmaceutical, Athenix Corp., Atlantic Breeders S. A. R. L., BUS C.V., Bayer (Proprietary) Limited, Bayer (Schweiz) AG, Bayer 04 Immobilien GmbH, Bayer 04 Leverkusen Fußball GmbH, Bayer A / S, Bayer AB, Bayer AS, Bayer Agriculture BVBA, Bayer Agriculture Limited, Bayer Algerie S. P. A., Bayer Altersversorgung GmbH, Bayer Animal Health GmbH, Bayer Austria Gesellschaft m.b.H., Bayer B.V., Bayer Beteiligungsverwaltung Goslar GmbH, Bayer Beteiligungsverwaltungsgesellschaft mbH & Co. OHG, Bayer Bitterfeld GmbH, Bayer Bulgaria EOOD, Bayer Business Services GmbH, Bayer Canadian Holdings Inc., Bayer Capital Corporation B.V., Bayer Chemicals GmbH, Bayer Consumer Care AG, Bayer Consumer Care Holdings LLC, Bayer Corporation, Bayer CropScience, Bayer CropScience (Portugal)-Produtos para a Agricultura Lda, Bayer CropScience Beteiligungsgesellschaft mit beschränkter Haftung, Bayer CropScience Biologics GmbH, Bayer CropScience Deutschland GmbH, Bayer CropScience Holding Inc., Bayer CropScience Holding SA, Bayer CropScience Holdings Inc., Bayer CropScience Inc., Bayer CropScience LLC, Bayer CropScience LP, Bayer CropScience Limited, Bayer CropScience NV, Bayer CropScience S. L., Bayer CropScience S. r. l., Bayer CropScience Schweiz AG, Bayer CropScience Vermögensverwaltungsgesellschaft mbH, Bayer East Coast LLC, Bayer Essure Inc., Bayer HealthCare Animal Health Inc., Bayer HealthCare Holdings LLC, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare US Funding II LLC, Bayer HealthCare US Funding LLC, Bayer Inc., Bayer International Trade Services Corporation, Bayer Medical Care Inc., Bayer New AU M1059 USD LLC, Bayer New AU M3650 LLC, Bayer New BE M3155 LLC, Bayer New CA M5015 LLC, Bayer New CH M3868 LLC, Bayer New CZ M3204 LLC, Bayer New DE M3385 LLC, Bayer New Gewas I M3640 LLC, Bayer New Gewas II M3640 LLC, Bayer New HU M3440 LLC, Bayer New MA M3130 LLC, Bayer New MX M3640 LLC, Bayer New MY M1455 LLC, Bayer New NL M3644 LLC, Bayer New Oogst M3648 LLC, Bayer New PL M3655 LLC, Bayer New RO M3695 LLC, Bayer New RU M3708 LLC, Bayer New TH M1763 LLC, Bayer New TK M3970 LLC, Bayer New UA M3702 LLC, Bayer New UK M3939 LLC, Bayer New Veggie M3617 M5157 LLC, Bayer New Veggie Mig M3617 M5157 LLC, Bayer New ZA M3743 LLC, Bayer Overseas Trade Services Corporation, Bayer Puerto Rico Inc., Bayer U.S. LLC, Bayer US Finance II LLC, Bayer US Finance LLC, Bayer US Holding LP, Bayer West Coast Corporation, Bayer World Investments B.V., Bayer d. o. o., Bayer spol. sr. o., Bayer-Handelsgesellschaft mit beschränkter Haftung, Beeologics Admin LLC, Beeologics Holdings Limited, Beeologics LLC, Beeologics USA Inc, Berlimed S. A., Berlipharm B.V., Berlis AG, Biogenetic Technologies B.V., BlueRock Therapeutics, Care/of, Channel Bio LLC, Chemion Logistik GmbH, Collateral Therapeutics Inc., Conceptus SAS La Garenne, Cooper Land Company of New Jersey Inc., Coppertone LLC, Corn States LLC, Dihon Pharmaceutical, Dr. Scholl’s LLC, Dritte Bayer Real Estate VV GmbH & Co. KG, Erste Bayer Real Estate VV GmbH & Co. KG, Erste K-W-A Beteiligungsgesellschaft mbH, EuroServices Bayer S. L., Fünfte Bayer Real Estate VV GmbH & Co., GP Grenzach Produktions GmbH, Grass Roots Biotechnology LLC, Hornbeck Seed Company Inc., Icon Genetics, Intendis GmbH, Intraserv GmbH & Co., Jenapharm GmbH & Co. KG, KVP Pharma+Veterinär Produkte GmbH, KWA Investment II LLC Research, KWA Investment III LLC, KWA Investment IV LLC, KaNDy Therapeutics, MENADIER Heilmittel GmbH, MNL Luxembourg S. a. r. l., MONSANTO Hungaria Kft., MONSANTO Saaten GmbH, Merck-Consumer Care (MCC), MiraLAX LLC, Monsanto ACUA MHC LLC, Monsanto AG Netherlands I C.V., Monsanto AG Netherlands II C.V., Monsanto AGN Holding LLC, Monsanto Ag B.V., Monsanto Agrar Deutschland GmbH, Monsanto Agricultura España S. L., Monsanto Agricultura Italia S.p.A., Monsanto Agriculture Nigeria Limited, Monsanto Burkina Faso SARL, Monsanto CR s. r. o., Monsanto Canada ULC, Monsanto Caribe LLC, Monsanto Company, Monsanto Crop B.V., Monsanto Crop Sciences Denmark A/S, Monsanto Crop Sciences Norway A/S, Monsanto Crop Sciences Sweden A.B., Monsanto Finance SA, Monsanto Gesellschaft m. b. H., Monsanto Gida Ve Tarim Ticaret Ltd, Monsanto Grain B.V., Monsanto Great Lakes Production Co LLC, Monsanto Hawaii Production Co LLC, Monsanto Hellas Agriculturals Ltd, Monsanto Holding I C.V., Monsanto Holding II C.V., Monsanto Holding III C.V., Monsanto Holding Ukraine Ltd, Monsanto Holland B.V., Monsanto II Lda, Monsanto Illinois Production Co LLC, Monsanto Inter-America Company, Monsanto International Sarl, Monsanto Invest B.V., Monsanto Iowa Production Co LLC, Monsanto Ireland Limited, Monsanto Jordan LLC, Monsanto Kenya Ltd, Monsanto Kool BV, Monsanto LA Holdings II Co LLC, Monsanto Latin America Holdings Co LLC, Monsanto MGCV MHC LLC, Monsanto MSCV Holding LLC, Monsanto MYCV MHC LLC, Monsanto Malawi Ltd, Monsanto Missouri Production Co LLC, Monsanto NL BV, Monsanto Northern Production Co LLC, Monsanto Oogst B.V., Monsanto Operations B.V., Monsanto Polska Sp. z o. o., Monsanto Production Supply LLC, Monsanto Romania SRL, Monsanto Rus LLC, Monsanto S.A.S., Monsanto Seed Supply LLC, Monsanto Seeds LLC, Monsanto Serbia D. O. O., Monsanto Slovakia S. R. O., Monsanto South Africa (PTY) Ltd, Monsanto Southern Production Co LLC, Monsanto Tanzania Limited, Monsanto Technology International LLC, Monsanto Technology LLC, Monsanto Treasury Services SARL, Monsanto UK Limited Cambridge U. K., Monsanto Vegetable Holding LLC, Monsanto Vegetable IP Holding C.V., Monsanto Vegetable IP Management BV, Monsanto Vegetable Seed Holding LLC, Monsanto Western Production Co LLC, Monsanto Zaad B.V., Monsanto Zambia Ltd, Monsanto d. o. o., Pallas Versicherung, Pandias Re AG, Pianosa B.V., Relay Limited, SC Bayer SRL, SCEA De Ruiter Zonen Selection, Sechste Bayer Real Estate VV GmbH & Co., Seminis Vegetable Seeds U. K. Ltd, Siebte Bayer VV GmbH, Steigerwald Arzneimittelwerk GmbH, TECTRION GmbH, TOO Bayer KAZ, The Climate Corporation International SA, TravelBoard GmbH, UAB Bayer, Vierte Bayer Real Estate VV GmbH & Co., WeatherMe OÜ, Zeptosens, Zoner.ag, Zweite Bayer Real Estate VV GmbH & Co., and Zweite K-W-A Beteiligungsgesellschaft mbH.

When was Bayer Aktiengesellschaft founded?

Bayer Aktiengesellschaft was founded in 1863.

What is Bayer Aktiengesellschaft's official website?

The official website for Bayer Aktiengesellschaft is www.bayer.com.

How can I contact Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49214301, via email at [email protected], or via fax at 49-21-4306-6328.

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.